Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Nov 21;174(1):209–218. doi: 10.1007/s10549-018-5056-8

Table 3.

Hazard ratios (HRs)a and 95% confidence intervals for the association between MetS and breast cancer mortality by menopausal status

Pre-menopausal Post-menopausal
Overall Overall Normal BMI Overweight/Obese
N (Deaths)b 3,693 (15) 90,662 (592) 41,652 (228) 49,009 (364)
MetSδ
 Crude NE 2.24 (1.43, 3.51) 1.45 (0.34, 6.15) 1.66 (0.90, 3.08)
 Adjusted § NE 2.07 (1.32, 3.25) 0.91 (0.22, 3.66) 1.15 (0.81, 1.64)
Components
 High WC 1.34 (0.23, 7.80) 1.45 (1.18, 1.78) 1.19 (0.70, 2.01) 1.32 (0.97, 1.79)
 High cholesterol 0.79 (0.27, 2.27) 1.21 (1.03, 1.42) 1.39 (1.05, 1.84) 1.16 (0.94, 1.43)
 High blood pressure 2.44 (0.85, 7.03) 1.28 (1.09, 1.51) 1.18 (0.88, 1.58) 1.21 (0.99, 1.49)
 High fasting glucose 1.42 (0.18, 11.09) 1.40 (1.04, 1.89) 1.38 (0.65, 2.94) 1.19 (0.86, 1.66)
Number of MetS Components
 0(Ref) 1.00 1.00 1.00 1.00
 1 0.75 (0.08, 7.48) 1.49 (1.05, 2.12) 1.72 (1.11, 2.67) 1.02 (0.57, 1.83)
 2 1.21 (0.10, 13.93) 2.05 (1.43, 2.94) 1.96 (1.14, 3.38) 1.45 (0.83, 2.53)
 3+ NE 2.09 (1.33, 3.28) 1.39 (0.33, 5.89) 1.42 (0.76, 2.64)
a,§

Models are adjusted for age (crude model), plus BMI, region,race,physical activity,smoking, and marital status.

b

Death = number of breast cancer deaths; N=number of observations.

δ

The reference category was women without any components of MetS.

Abbreviation: MetS, metabolic syndrome; NE, not estimable; Ref, reference; WC, waist circumference.

Bold indicates statistically significant at α= 0.05.